Moberg Pharma AB (publ) operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Moberg Pharma AB (publ) with three other
pharmaceutical manufacturers in Europe:
sales of 26.37 million Euro [US$28.94 million]
Horizon Discovery Group PLC
of the United Kingdom
(£20.16 million [US$24.76 million]
of which 60%
was Services), and
based in Russia
(1.70 billion Russian Rubles [US$27.29 million]
Moberg Pharma AB (publ) reported sales of SEK 285.57 million (US$32.32 million)
December of 2015.
increase of 42.7%
versus 2014, when the company's sales were SEK 200.18 million.
Sales at Moberg Pharma AB (publ) have increased during each of the previous five years
(and since 2010, sales have increased a total of 3,255%).
Sales of Other Products saw an increase
that was more than double the company's growth rate: sales were up
140.3% in 2015, from
SEK 25.36 million to SEK 60.94 million.